|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4709 | (2006.01) |
| A61K 31/4709 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Number of the document | 3542800 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19172562.1 |
| Date of filing the European patent application | 2018-02-21 | |
| (97) | Date of publication of the European application | 2019-09-25 |
| (45) | Date of publication and mention of the grant of the patent | 2022-06-01 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201762461602 P | 2017-02-21 | US | |
| 201762507749 P | 2017-05-17 | US | |
| 201762519819 P | 2017-06-14 | US | |
| 201715820157 | 2017-11-21 | US | |
| 201715820012 | 2017-11-21 | US | |
| 201762596653 P | 2017-12-08 | US |
| (72) |
GUALBERTO, Antonio , US
SCHOLZ, Catherine Rose , US
|
| (73) |
Kura Oncology, Inc. ,
12730 High Bluff Drive, Suite 400, San Diego, CA 92130,
US
|
| (54) | METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS |
| METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS |